Hemostasis management and therapeutic plasma exchange: Results of a practice survey

• Published in: Journal of clinical apheresis 2018-10, Vol.33 (5), p.604-610
• Main Authors: Zantek, Nicole D., Boral, Leonard I., Li, Yanhua, Yamada, Chisa, Svensson, Annika M., Crane, Jason E., Smith, Roy E., Pagano, Monica B., Rollins‐Raval, Marian A., Schmidt, Amy E., Wong, Edward C. C., Wu, Yanyun
• Format: Article
• Language: English
• Subjects: anticoagulation; Apheresis; bleeding; coagulation; Fluids; plasmapheresis
• ISSN: 0733-2459; 1098-1101
• DOI: 10.1002/jca.21653

Background Patients undergoing therapeutic plasma exchange (TPE) may present with risks for hemorrhage or thrombosis. Use of replacement fluids devoid of coagulation factors will decrease factor levels and platelet levels. There are no established guidelines for hemostasis management in these situations. Materials and methods A survey to evaluate current hemostasis management practice during TPE was conducted using online survey software. One response per institution was analyzed based on a hierarchical algorithm, excluding membrane filtration users, resulting in a maximum of 107 respondents. Descriptive analysis was performed with results reported as the number and frequency (%) of respondents to each question. Results Apheresis Medicine physicians, alone (59.4%) or jointly with the requesting provider (29.2%), choose the replacement fluid. Based on a theoretical patient case receiving five TPEs approximately every other day, the percent of respondents who would use albumin with or without normal saline was 94.7% with no history of a bleeding or clotting disorder, 1.1% with active bleeding, and 8.8% with hypofibrinogenemia (